BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 30, 2008
View Archived Issues
Santen patents novel HDAC inhibitors for glaucoma
Read More
Recent patents divulge novel analgesic agents
Read More
Novel agents for treating thrombosis disclosed in recent Wyeth patent
Read More
Clinical Data and Avalon enter into definitive merger agreement
Read More
Broad-spectrum antifungal activity seen with AN-2718 in vitro
Read More
Studies detail effects of prucalopride in chronic constipation, intestinal pseudo-obstruction
Read More
CombinatoRx provides data from phase IIb osteoarthritis study with Synavive
Read More
Chelsea completes enrollment in phase II clinical trial of CH-1504 in RA
Read More
Nycomed reports encouraging results from four phase III trials of Daxas in COPD
Read More
Provectus successfully completes phase I clinical trial of PV-10 in recurrent breast cancer
Read More
BioWa licenses Potelligent to KaloBios
Read More
Wakunaga identifies novel fluoroquinolone with activity against resistant respiratory bacteria
Read More
Cipher provides update on CIP-Tramadol ER regulatory filing
Read More
EMD Serono and Theratechnologies collaborate for tesamorelin in the U.S.
Read More
HealthLinx launches OvPlex ovarian cancer screening test in Australia
Read More
BioMimetic reports clinical results using Augment Injectable Bone Graft
Read More
Northfield Laboratories submits BLA to FDA for PolyHeme red cell substitute
Read More
Bristol-Myers Squibb presents studies of BMS-582949 in humans
Read More
Oral formulation of 17-AAG metabolite IPI-493 displays potency, in vivo activity
Read More
Phenomix initiates treatment in phase Ia clinical trial of protease inhibitor PHX-1766 in HCV
Read More
Phase I and other data on HDAC inhibitor SB-939 presented
Read More
Applied Biosystems stockholders approve proposed merger with Invitrogen
Read More
South Africa Medicines Control Council discontinues registration of Biopure's Hemopure
Read More
Anadys initiates dosing in phase Ib clinical trial of ANA-598 in HCV infection
Read More
FDA approves sanofi-aventis' Apidra insulin for diabetic children aged 4 years and older
Read More
ImClone Systems launches monoclonal antibody Erbitux in Canada for mCRC
Read More